SCHEMBL20002980

SCHEMBL20002980

O=C(N1CCCC(CO)C1)N1CCC(S(=O)(=O)c2ccc(F)cc2)C1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.59
CYP3A4 P08684 1/20 0.59
RORC P51449 2/20 0.47
EPHX2 P34913 5/20 0.44
HTR2A P28223 3/20 0.44
HTR2C P28335 2/20 0.44
KCNH2 Q12809 2/20 0.44
MAPT P10636 1/20 0.42
DRD2 P14416 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
POLB P06746 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
LIPE Q05469 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20002563 0.88 EPHX2 (0.45) CYP2C19CYP3A4EPHX2HTR2AHTR2C
SCHEMBL20003003 0.83 EPHX2 (0.45) CYP2C19CYP3A4RORCEPHX2HTR2A
SCHEMBL20002933 0.82 RORC (0.46) CYP2C19CYP3A4RORCEPHX2HTR2A
SCHEMBL20003031 0.81 EPHX2 (0.44) CYP2C19CYP3A4RORCEPHX2HTR2A
SCHEMBL20002321 0.81 CCR5 (0.46) RORCEPHX2
SCHEMBL20002459 0.81 RORC (0.51) RORCEPHX2HTR2AHTR2CKCNH2
SCHEMBL20002322 0.81 PKM (0.60) RORCEPHX2HTR2AHTR2CKCNH2
SCHEMBL20002221 0.81 RORC (0.45) RORCEPHX2HTR2AHTR2CKCNH2
SCHEMBL20003053 0.81 CCR5 (0.46) RORCEPHX2
SCHEMBL20003007 0.81 RORC (0.44) CYP2C19CYP3A4RORCEPHX2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3092229-B1 PYRROLIDINYL SULFONE DERIVATIVES AND THEIR USE AS ROR GAMMA MODULATORS BRISTOL MYERS SQUIBB CO (US) 2018-03-28 EP disclosed